Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04964609
Other study ID # CIP-4
Secondary ID EMPA01
Status Completed
Phase N/A
First received
Last updated
Start date June 16, 2021
Est. completion date November 21, 2022

Study information

Verified date November 2022
Source Empatica, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to test the accuracy of EmbracePlus computed SpO2 during mild, moderate and severe hypoxia (a lower-than-normal concentration of oxygen in arterial blood); ie, a range of arterial HbO2 saturations from 100 to down to 70%. This is done by comparing the reading of the the subject device during brief, steady state hypoxia with a gold-standard measurement of blood oxyhemoglobin (hemoglobin carrying oxygen) saturation, that is arterial blood sample processed in a laboratory.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date November 21, 2022
Est. primary completion date November 21, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - The subject is male or female, aged =18 and <50. - The subject is in good general health with no evidence of any medical problems. - The subject is fluent in both written and spoken English. - The subject has provided informed consent and is willing to comply with the study procedures. Exclusion Criteria: - The subject is obese (BMI>30). - The subject has a known history of heart disease, lung disease, kidney or liver disease. - Diagnosis of asthma, sleep apnea, or use of CPAP. - Subject has diabetes. - Subject has a clotting disorder. - The subject a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation. - The subject has any other serious systemic illness. - The subject is a current smoker. - Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly. - The subject has a history of fainting or vasovagal response. - The subject has a history of sensitivity to local anesthesia. - The subject has a diagnosis of Raynaud's disease. - The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test). - The subject is pregnant, lactating or trying to get pregnant. - The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures. - The subject has any other condition, which in the opinion of the investigators' would make them unsuitable for the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EmbracePlus
A device intended for use by researchers and healthcare professionals for continuous collection of physiological parameters in home and healthcare settings. Parallel blood gas analysis to determine oxyhemoglobin saturation (SaO2) using an ABL-90 multi-wavelength oximeter.

Locations

Country Name City State
United States Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California San Francisco California

Sponsors (2)

Lead Sponsor Collaborator
Empatica, Inc. Empatica Srl

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary SpO2 Accuracy SpO2 as measured by the subject device during periods of low motion will be compared to the oxyhemoglobin saturation (SaO2) as measured by direct oximetry with a Radiometer ABL-90 multi-wavelength oximeter Through study completion, 3 months average
See also
  Status Clinical Trial Phase
Completed NCT01530360 - Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants Phase 1
Completed NCT03710980 - Accuracy of Pulse Oximeters With Profound Hypoxia
Recruiting NCT06015204 - Assessment of the C8 Dermatomal Block With Photoplethysmographic Amplitude After Interscalene Brachial Plexus Block N/A
Completed NCT03250065 - The Sensing ET Tube N/A
Completed NCT04380389 - Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia N/A
Completed NCT04562584 - Pulse Oximeter Hypoxia N/A
Recruiting NCT04587921 - Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 N/A
Completed NCT03710993 - Accuracy Assessment of Beddr Oximeter
Completed NCT04324385 - Accuracy of Pulse Oximeters With Profound Hypoxia
Completed NCT03534271 - The Accuracy of Smartphone Pulse Oximetry in Patients Visiting an Outpatient Pulmonary Function Lab for a 6-Minute Walk Test